Laboratory-acquired parasitic infections from accidental exposures.
about
Chagas disease in the 21st century: a public health success or an emerging threat?Epidemiology of human African trypanosomiasisEvidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment MeasuresCombined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivoA panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection modelsLinalool, a Piper aduncum essential oil component, has selective activity against Trypanosoma cruzi trypomastigote forms at 4°CSeroprevalence of T. cruzi infection in blood donors and Chagas cardiomyopathy in patients from the coal mining region of Coahuila, MexicoNatural Chagas disease in four baboons.Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies.Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.Arboprotozoae.Survey of obstetrician-gynecologists in the United States about Chagas disease.Epidemiology of and diagnostic strategies for toxoplasmosisIdentification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.Accidental infection of laboratory worker with vaccinia virus.Considerations for the use of human participants in vector biology research: a tool for investigators and regulators.Glomerulonephropathies in Plasmodium inui-infected rhesus monkey: a primate model and possible applications for human quartan malaria.Trypanosoma cruzi and Chagas' Disease in the United StatesExperimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.Unusual transmission of Plasmodium falciparum, Bordeaux, France, 2009.Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health BiotechnologyLeishmaniasis in the United States: treatment in 2012Integrated control of Chagas disease for its elimination as public health problem--a reviewTherapy of chagas disease: implications for levels of prevention.Vector-borne transmission of Trypanosoma cruzi among captive Neotropical primates in a Brazilian zooTransmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature ReviewA cross-sectional study of intestinal parasitic infections in a rural district of west China.Occupationally acquired american cutaneous leishmaniasisBenznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.An update on the management of Chagas cardiomyopathy.Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?A loop-mediated isothermal amplification (LAMP) assay for Strongyloides stercoralis in stool that uses a visual detection method with SYTO-82 fluorescent dye.Concomitant Infection with Leishmania donovani and L. major in Single Ulcers of Cutaneous Leishmaniasis Patients from Sudan.Congenital transmission of Chagas disease: a clinical approach.Diagnosis and management of Chagas disease and cardiomyopathy.2 nd Brazilian Consensus on Chagas Disease, 2015.Human Toxocariasis: Prevalence and Factors Associated with Biosafety in Research Laboratories.A LiTat 1.5 variant surface glycoprotein-derived peptide with diagnostic potential for Trypanosoma brucei gambiense.Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.Cryptosporidiosis outbreak at an academic animal research laboratory-Colorado, 2014.
P2860
Q24594371-8E0B19E9-0BA6-42A9-812F-598EDE993A86Q27026504-CC93E133-D709-4204-A967-915839C30059Q27486575-D8121913-6937-4252-A5C0-922E16DFD430Q28479294-A8238614-0E1D-4918-B241-9FDD053B1184Q28542468-8B368C27-1D79-4E87-B134-10F7DFE44CDBQ28817421-B379C2AC-74CF-410C-A21C-013FAB1305B9Q33859647-50F3C4A2-16BF-42AF-86E6-63AD0326F113Q33908580-2774C44C-83C5-4519-9140-DD3019F89D6AQ33918063-E83A02C3-52A5-427F-BBD5-7F1436E134EFQ33939308-99795D61-2FDB-411F-8B66-23555C01C08DQ34086340-282D3EF2-A20E-4C57-9CE3-D457EF363B62Q34160168-B2E9ED8B-0610-4435-B02A-0C337D08D7DFQ34267180-73D0EEF5-9CC2-4B5D-93AF-11937E6A5A2AQ34312405-85C9DF36-F047-4E84-BF2E-BF05A4E04728Q34396389-D2922B8B-3AC3-439B-A29B-ED8B997AAEB0Q35121975-CF082989-BEB6-4E92-9F5F-78DF44E91031Q35206737-91264D4B-2F41-4CDD-BEA9-31AF4EEF9658Q35361594-EC20BA60-8356-403D-818C-1EB0738EB5B2Q35367533-04D31CAD-AC88-411A-938A-368FB598C921Q35484051-2F297559-EC19-4C6B-81C2-C2045AA2348EQ35545777-FA4A44ED-4C18-459F-BB86-0C4D20365848Q35771790-9E5043C0-F8E3-4898-AAFE-1E98BB075E54Q35810731-CEF3E89E-D163-41A4-8C8A-68DA36DE9A82Q35864834-AC036DC0-0619-4436-9AED-55F14E95B433Q35905259-042F03AB-1282-47A1-BA10-8FA3AA417B39Q36094815-FAF8F58B-24E5-4F83-8A62-1711C1F31C7EQ36170759-5487CD5E-418A-4D3B-AE86-5F4212AB4B8FQ36446635-F43E1B64-DF0E-452B-971E-3E69C922C893Q36729990-6BCCE9E2-D8C6-4936-AA03-237A06E0098AQ36901974-AA9AA4BD-D365-430D-AEAC-44E27C5505F3Q36933164-20AC11C2-E12F-43AC-8D84-70FFA4B70C35Q37572964-6704FC98-31FF-48F3-923D-082A2C5D7EAAQ37679657-0B8F1573-7653-472C-BA92-645ECC1F16F4Q37778830-E3B4C17C-D296-4373-B1C4-C6C8A3BD70FDQ38030830-8E104466-2AB4-4763-971D-63279D77B319Q38972541-48434382-175B-4C45-A902-0D8964AB9970Q39326715-B6F433FF-70AF-4300-81EA-60EDAA77FBEFQ39551459-EBA9A836-0A0D-4DC5-8029-65C8105E0C6EQ40063941-2F75FA18-1C96-4B25-B411-AA86FDC72440Q40375127-4AB78471-14D5-4044-BD11-D5B466B8FA9E
P2860
Laboratory-acquired parasitic infections from accidental exposures.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Laboratory-acquired parasitic infections from accidental exposures.
@ast
Laboratory-acquired parasitic infections from accidental exposures.
@en
type
label
Laboratory-acquired parasitic infections from accidental exposures.
@ast
Laboratory-acquired parasitic infections from accidental exposures.
@en
prefLabel
Laboratory-acquired parasitic infections from accidental exposures.
@ast
Laboratory-acquired parasitic infections from accidental exposures.
@en
P2860
P1476
Laboratory-acquired parasitic infections from accidental exposures.
@en
P2093
B L Herwaldt
P2860
P304
659-88, table of contents
P356
10.1128/CMR.14.3.659-688.2001
P407
P577
2001-10-01T00:00:00Z